I believe that Elite's twice a day will be supported by Actavis at some point including trials at some point once they get through an initial study to prove safety and blood levels. There may be a crush study but Elite did one of those before, not sure if on twice daily though.
Actavis needs a product and/or IP with their deal with Purdue. And if Actavis carriers the weight on this one, much can be used to get the once daily as an ANDA I believe with much cheaper trials.
(0)
(0)
Elite Pharmaceuticals Inc (ELTP) Stock Research Links